BIOSPECIFICS TECHNOLOGIES CORP - FORM 10-K - EX-23.2 - EXHIBIT 23.2 - March 14, 2016

Attached files

file filename
EX-32.1 - EXHIBIT 32.1 - BIOSPECIFICS TECHNOLOGIES CORPex32_1.htm
EX-21.1 - EXHIBIT 21.1 - BIOSPECIFICS TECHNOLOGIES CORPex21_1.htm
EX-23.1 - EXHIBIT 23.1 - BIOSPECIFICS TECHNOLOGIES CORPex23_1.htm
EX-10.19 - EXHIBIT 10.19 - BIOSPECIFICS TECHNOLOGIES CORPex10_19.htm
EX-10.20 - EXHIBIT 10.20 - BIOSPECIFICS TECHNOLOGIES CORPex10_20.htm
EX-31.1 - EXHIBIT 31.1 - BIOSPECIFICS TECHNOLOGIES CORPex31_1.htm
10-K - BIOSPECIFICS TECHNOLOGIES CORP 10-K 12-31-2015 - BIOSPECIFICS TECHNOLOGIES CORPform10k.htm
Exhibit 23.2

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
 
 
We hereby consent to the incorporation by reference in the Registration Statement on Form S-8 (No. 333-160583) of BioSpecifics Technologies Corp. of our reports dated March 6, 2014 relating to the consolidated financial statements of BioSpecifics Technologies Corp. and effectiveness of BioSpecifics Technologies Corp.’s internal control over financial reporting, which reports appear in the December 31, 2015 annual report on Form 10-K of BioSpecifics Technologies Corp.
 
/s/    Tabriztchi & Co., CPA, P.C.

Garden City, New York
March 14, 2016
 

Stock widget

Investing forum

BIOSPECIFICS TECHNOLOGIES CORP Reports